##  [Novartis announces NEJM publication of two pivotal Phase III secukinumab studies demonstrating statistically significant skin clearance in psoriasis patients](/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients-0 "Novartis announces NEJM publication of two pivotal Phase III secukinumab studies demonstrating statistically significant skin clearance in psoriasis patients") 

  Jul 09, 2014